FDA NDC Directory · JSON-LD · Markdown

BIVALIRUDIN

NDC 71288-427 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerMeitheal Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091602
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsBIVALIRUDIN (250 mg/5mL)
Marketing started20180716
Package count1

External sources

Source: openFDA. Public-domain (CC0).